KRAS and lung adenocarcinoma: It is worth noting that the data presented on the A549 non-small cell lung cancer cell line correspond to a lung adenocarcinoma cell line, which specifically carries KRAS and CDKN2A gene mutation, with KRAS being one of the most commonly observed mutations in LC [50].